Comera Life Sciences (CMRA) Insider Trading & Ownership Add Compare Share Share Insider Trades Stock AnalysisChartCompetitorsInsider TradesSEC FilingsShort InterestTrendsBuy This Stock Comera Life Sciences (NASDAQ:CMRA) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage8.90%Number OfInsiders Buying(Last 3 Years)3Amount OfInsider Buying(Last 3 Years)$1.50MNumber OfInsiders Selling(Last 3 Years)0 Get CMRA Insider Trade Alerts Want to know when executives and insiders are buying or selling Comera Life Sciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CMRA Insider Buying and Selling by Quarter Comera Life Sciences Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails9/11/2023Charles CheringtonMajor ShareholderBuy2,053,789$0.51$1,047,432.39 8/14/2023Robert Patrick MahoneyInsiderBuy20,000$0.63$12,600.00 7/31/2023David SoaneMajor ShareholderBuy273,838$0.51$139,657.38 1/4/2023David SoaneMajor ShareholderBuy202,701$1.23$249,322.23 11/8/2022David SoaneMajor ShareholderBuy3,000$1.38$4,140.00 10/20/2022Charles CheringtonMajor ShareholderBuy3,316$1.52$5,040.32 10/17/2022Charles CheringtonMajor ShareholderBuy15,266$1.66$25,341.56 10/13/2022Charles CheringtonMajor ShareholderBuy10,481$1.66$17,398.46 (Data available from 1/1/2013 forward) CMRA Insider Trading Activity - Frequently Asked Questions Who is on Comera Life Sciences' Insider Roster? The list of insiders at Comera Life Sciences includes Charles Cherington, David Soane, and Robert Patrick Mahoney. Learn more on insiders at CMRA. What percentage of Comera Life Sciences stock is owned by insiders? 8.90% of Comera Life Sciences stock is owned by insiders. Learn more on CMRA's insider holdings. Comera Life Sciences Key ExecutivesMr. Michael G. Campbell CPA (Age 55)CEO, CFO & Principal Accounting Officer Compensation: $269.11kDr. David Soane Ph.D.Co-Founder & Member of Scientific Advisory BoardMs. Janice Marie McCourt B.S. (Age 62)CLP, M.B.A., R.Ph., Chief Business Officer More Insider Trading Tools from MarketBeat Related Companies EVLO Insider Trading SMFL Insider Trading SYRS Insider Trading PXMD Insider Trading EFTR Insider Trading BTMDW Insider Trading CALA Insider Trading CLVRW Insider Trading CLVR Insider Trading FBIOP Insider Trading Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Oklo Insiders Sell! Oh No! This Is Why Investors Shouldn’t WorryTop Insider Buys and Sells From September: Buy, Sell, or Hold?NuScale, Rocket Lab Face Heavy Insider Selling After Surges3 Small Caps That Insiders Are Buying $100 Million Buyback in Upwork Stock Follows a Strong Quarter This page (NASDAQ:CMRA) was last updated on 10/4/2025 by MarketBeat.com Staff From Our PartnersNvidia CEO Makes First Ever Tesla AnnouncementWhile headlines focus on Tesla’s car sales, tech analyst Jeff Brown says the real story is Tesla’s role in a $...Brownstone Research | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredNvidia’s slow death marchEric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredAltucher: It Looks Like My Trump prediction is coming trueNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredThe Fed Just Got Kneecapped — Here’s What Happens NextDonald Trump has done it again! This time, with the signing of the highly controversial new law S.1582 — he...Banyan Hill Publishing | SponsoredMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Comera Life Sciences Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Comera Life Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
